| 来源类型 | Working Paper |
| 规范类型 | 报告 |
| DOI | 10.3386/w13125 |
| 来源ID | Working Paper 13125 |
| End-stage Renal Disease and Economic Incentives: The International Study of Health Care Organization and Financing | |
| Avi Dor; Mark V. Pauly; Margaret A. Eichleay; Philip J. Held | |
| 发表日期 | 2007-05-24 |
| 出版年 | 2007 |
| 语种 | 英语 |
| 摘要 | End-stage renal disease (ESRD), or kidney failure, is a debilitating, costly, and increasingly common medical condition. Little is known about how different financing approaches affect ESRD outcomes and delivery of care. This paper presents results from a comparative review of 12 countries with alternative models of incentives and benefits, collected under the International Study of Health Care Organization and Financing, a substudy within the Dialysis Outcomes and Practice Patterns Study. Variation in spending per ESRD patient is relatively small and is correlated with overall per capita health care spending. Between-country variations in spending are reduced using an input price parity index constructed for this study. Remaining differences in costs and outcomes do not seem strongly linked to differences in incentives embedded in national programs. |
| 主题 | Health, Education, and Welfare ; Health |
| URL | https://www.nber.org/papers/w13125 |
| 来源智库 | National Bureau of Economic Research (United States) |
| 引用统计 | |
| 资源类型 | 智库出版物 |
| 条目标识符 | http://119.78.100.153/handle/2XGU8XDN/570793 |
| 推荐引用方式 GB/T 7714 | Avi Dor,Mark V. Pauly,Margaret A. Eichleay,et al. End-stage Renal Disease and Economic Incentives: The International Study of Health Care Organization and Financing. 2007. |
| 条目包含的文件 | ||||||
| 文件名称/大小 | 资源类型 | 版本类型 | 开放类型 | 使用许可 | ||
| w13125.pdf（353KB） | 智库出版物 | 限制开放 | CC BY-NC-SA | 浏览 | ||
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
